ATM GENE MUTATION
Clinical trials for ATM GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new ATM GENE MUTATION trials appear
Sign up with your email to follow new studies for ATM GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope: targeted drug olaparib shows promise for Hard-to-Treat breast cancer
Disease control OngoingThis study tests a drug called olaparib in people with metastatic breast cancer that has spread beyond the breast. Participants must have a specific genetic change in their tumor that may make it sensitive to this drug. The goal is to see if olaparib can shrink tumors or slow can…
Matched conditions: ATM GENE MUTATION
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated May 26, 2026 09:01 UTC
-
New hope for hard-to-treat cancers with BRCA gene changes
Disease control OngoingThis study tests a drug called talazoparib in 150 adults whose advanced cancer has stopped responding to standard treatments. The drug works by blocking an enzyme that helps tumor cells survive, and is given to people whose tumors have specific changes in BRCA or related genes. T…
Matched conditions: ATM GENE MUTATION
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:55 UTC